January 27 2023

Start-up LinKinVax and Gustave Roussy enter into a collaboration to conduct a Phase I/IIa HPV.DCVax clinical trial for the treatment of patients with human papillomavirus (HPV) associated oropharyngeal cancer

January 3 2023

Congratulations to Pr. Josselin Houenou, Marion Leboyer’s team, winner of the Matmut Prize for Medical Innovation 2022

November 28 2022

AAP of the ARC Foundation “Cancer and Aging”: Congratulations to Serge Adnot, from the team of G. Derumeaux, biological coordinator of the project, and Florence Canouï-Poitrine and Christos Chouaid from the team S. Bastuji-Garin, team associated with the project: “Identification of biomarkers of aging to better adapt the treatment of bronchial cancers in elderly subjects. A clinico-biological approach in 2 steps”, which has just been selected by the ARC Foundation

July 11 2022

Visiting IMRB for her first official visit, Mrs. Sylvie RETAILLEAU, Minister of Higher Education and Research did not come empty-handed!

July 4 2022

Congratulations to Laura Fertitta from the Mondor Neurofibromatosis Reference Center, Pierre Wolkenstein, CRN Mondor and IMRB-Gaulard team, and Piotr Topilko, IMRB-Gaulard team, who have just successfully applied to the prestigious Francis S. Collins Scholarship program at John Hopkins University!

April 25 2022

Congratulations to Maëlle BRIOTTET, doctoral student in Sophie Lanone’s team in Valérie Urbach’s group, who received the Prize of the association Vaincre la Mucoviscidose during the French Symposium for Young Researchers

April 19 2022

Omicron variant: Vaccination reveals a strong but incomplete immune escape. A study signed by Matthieu Mahévas’ group within the France Pirenne team and published this month in Immunity

April 8 2022

A new treatment for post-transplant leukemia relapse! A study by José Cohen’s I-BIOT team published this month in the Journal for Immunotherapy of cancer

March 1 2022

The DIM One Health 2.0 project led by Inserm and Prof. Jean-Daniel Lelièvre, accredited by the Ile-de-France region

February 21 2022

Artificial intelligence predicts immune and inflammatory genetic signatures directly from hepatocellular carcinoma histology. A study led by Prof. Julien Calderaro and published in Journal of Hepatology

February 7 2022

The FRM labels Bijan Ghaleh’s team for its project “The heme as a danger molecule during myocardial infarction”.

January 31 2022

Publication in Nature Medicine of the long-term results of the HGB-205 gene therapy trial for beta-hemoglobinopathies, conducted at the Necker Hospital and for which the analyses of patients with sickle cell disease were carried out by the France Pirenne team (N. Hebert, L. Kiger, P. Bartolucci).

January 24 2022

Publication in Lancet of the results of the SEPREVEN* study: randomized trial conducted in 12 neonatal intensive care units in France with the theme of patient safety.

January 5 2022

Publication in the Journal of the American College of Cardiology (IF 24.09) of a study on the identification of typical clinical profiles in patients with suspected cardiac amyloidosis

December 18 2021

Publication of an article and editorial in the journal JACC on the beneficial effect of Ryanodine receptor stabilization to improve left ventricular function in young dogs with Duchenne muscular dystrophy

December 13 2021

Publication of a study in Clinical Cancer Research on the identification of two main immune subtypes of cHCC-CCA (“Immune High” and “Immune Low”) in patients with mixed hepatocholangiocarcinoma tumors